Purpose Lobular carcinoma in situ (LCIS) is a marker of increased risk of breast cancer.
Current guidelines do not recommend mastectomy as a strategy for risk reduction for most …

Purpose A diagnosis of lobular carcinoma in situ (LCIS) is associated with an increased risk
of developing breast cancer, although little data exist on long-term patient outcomes …

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic
Features and Breast Cancer Risk - PMC Back to Top Skip to main content NIH NLM Logo …

Background Lobular carcinoma in situ (LCIS) is known to be a risk factor for the
development of invasive breast cancer. Debate continues as to whether LCIS is also a …

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) represent a
spectrum of breast disease referred to as" lobular neoplasia"(LN). Although LN occurs …

Aim Lobular carcinoma in situ (LCIS) is a known risk factor for invasive breast carcinoma, but
there is increasing data indicating a possible precursor relationship. This study investigates …

Background: The finding of lobular carcinoma in situ (LCIS) in the breast has generally
prompted treatment with unilateral or bilateral mastectomy. Most experts now feel that LCIS …

Background Studies report low upgrade rates following excision for classic-type lobular
carcinoma in situ (LCIS) with radiologic-pathologic concordance. Thus, in the absence of …

BACKGROUND Extant information reveals inconsistencies concerning the natural history,
pathologic features, and treatment of lobular carcinoma in situ (LCIS) of the breast. It is …